NUTRA PHARMA CORP. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $0.00.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $12.00K.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-12-31 was $0.00.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $2.50K.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $2.50K, a 93.06% decline from fiscal 2022.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $36.00K, a 98.46% decline from fiscal 2021.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $2.34M, a 192.65% increase from fiscal 2020.
- NUTRA PHARMA CORP. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $801.10K, a 191.31% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | |
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-29 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.50K 10-K · filed 2026-02-17 |
| 2023-09-30 | $2.50K 10-Q · filed 2026-01-02 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-24 | $36.00K 10-K · filed 2025-11-24 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $36.00K derived: sum of 4 quarters · filed 2025-10-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-10-23 | $36.00K derived: sum of 4 quarters · filed 2025-10-23 |
| 2022-03-31 | $36.00K 10-Q · filed 2025-10-16 | $279.79K derived: sum of 4 quarters · filed 2025-10-16 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-03 | $2.34M 10-K · filed 2025-09-03 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $2.55M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $243.79K 10-Q · filed 2022-08-22 | $2.72M derived: sum of 4 quarters · filed 2022-08-22 |
| 2021-03-31 | $2.10M 10-Q · filed 2022-05-20 | $2.48M derived: sum of 4 quarters · filed 2022-05-20 |
| 2020-12-31 | $204.69K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $801.10K 10-K · filed 2022-04-15 |
| 2020-09-30 | $171.41K 10-Q · filed 2021-11-10 | $596.41K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24 | $425.00K derived: sum of 4 quarters · filed 2021-09-24 |
| 2020-03-31 | $425.00K 10-Q · filed 2021-09-17 | $700.00K derived: sum of 4 quarters · filed 2021-09-17 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-08 | $275.00K 10-K · filed 2021-09-08 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | |
| 2019-06-30 | $275.00K 10-Q · filed 2021-08-05 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-01 | $2.43M 10-K · filed 2021-07-01 |
| 2018-09-30 | $519.56K 10-Q · filed 2021-05-14 | |
| 2018-06-30 | $1.15M 10-Q · filed 2021-05-07 | |
| 2018-03-31 | $1.01M 10-Q · filed 2021-04-05 | |
| 2013-12-31 | $1.65M 10-K · filed 2014-03-31 | |
| 2012-12-31 | $1.35M 10-K · filed 2014-03-31 |